This clinical pattern was consistent with the aforementioned body-first model, which was characterized by more severe autonomic symptoms, prodromal RBD, faster progression and a higher global burden of alpha-synuclein pathology compared to brain-first PD without RBD [12]. The gene discussed is SNCA; the disease is Parkinson disease.